| Adenosine triphosphate in the treatment of supraventricular tachycardia. | |
| | |
MedLine Citation:
|
PMID: 8444037 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The efficacy of adenosine triphosphate (ATP, Spofa) in controlling supraventricular tachycardia (SVT) was assessed in a group of 20 consecutive patients with this condition. Sinus rhythm was restored in a total of 19 patients (95% efficacy). SVT termination was followed, in a full 40% of patients, by asystole with a mean duration of 8.6 seconds; there were, however, no sequelae and no measures had to be taken. ATP can be regarded as a welcome addition to the current range of pharmacological options available for the treatment of SVT. |
| | |
Authors:
|
J Sochman |
Related Documents
:
|
17951267 - A randomized trial comparing two different approaches of pacemaker selection. 15071247 - Multisite atrial pacing for atrial fibrillation prevention: where to go from here? 2496977 - Flecainide and cardiac dysrhythmias during dental extraction under anaesthesia. 10376927 - Management of vasovagal syncope. 21732977 - Omega-3 polyunsaturated essential fatty acids are associated with depression in adolesc... 16205047 - Value of apache ii, sofa and cpis scores in predicting prognosis in patients with venti... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Cor et vasa Volume: 35 ISSN: 0010-8650 ISO Abbreviation: Cor Vasa Publication Date: 1993 |
Date Detail:
|
Created Date: 1993-04-07 Completed Date: 1993-04-07 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 0372614 Medline TA: Cor Vasa Country: CZECHOSLOVAKIA |
Other Details:
|
Languages: eng Pagination: 24-6 Citation Subset: IM |
Affiliation:
|
Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech republic. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adenosine Triphosphate
/
therapeutic use* Adult Aged Female Humans Male Middle Aged Tachycardia, Supraventricular / drug therapy* |
| Chemical | |
Reg. No./Substance:
|
56-65-5/Adenosine Triphosphate |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Following PTCA exercise tolerance is only moderately correlated with cinevideo-densitometric measure...
Next Document: The intima of the common carotid artery in patients with hyperlipoproteinemia